News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
879,003 Results
Type
Article (88426)
Company Profile (732)
Press Release (789823)
Multimedia
Podcasts (234)
Webinars (35)
Section
Business (233403)
Career Advice (4161)
Deals (39961)
Drug Delivery (175)
Drug Development (91541)
Employer Resources (207)
FDA (18481)
Job Trends (17478)
News (398267)
Policy (39979)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3045)
Academic (2)
Accelerated approval (51)
Adcomms (38)
Allergies (184)
Alliances (56971)
ALS (223)
Alzheimer's disease (1947)
Antibody-drug conjugate (ADC) (515)
Approvals (18802)
Artificial intelligence (797)
Autoimmune disease (334)
Automation (58)
Bankruptcy (406)
Best Places to Work (12623)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (450)
Bladder cancer (205)
Brain cancer (77)
Breast cancer (786)
Cancer (6160)
Cardiovascular disease (512)
Career advice (3595)
Career pathing (51)
CAR-T (363)
CDC (67)
Celiac Disease (2)
Cell therapy (1012)
Cervical cancer (51)
Clinical research (78454)
Collaboration (2283)
Company closure (8)
Compensation (1345)
Complete response letters (95)
COVID-19 (3023)
CRISPR (121)
C-suite (1223)
Cystic fibrosis (165)
Data (8243)
Decentralized trials (3)
Denatured (89)
Depression (180)
Dermatology (92)
Diabetes (606)
Diagnostics (7500)
Digital health (58)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (385)
Drug pricing (228)
Drug shortages (37)
Duchenne muscular dystrophy (305)
Earnings (101984)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137568)
Executive appointments (1140)
FDA (22292)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (17)
Frontotemporal dementia (36)
Funding (1831)
Gene editing (263)
Generative AI (80)
Gene therapy (829)
GLP-1 (1203)
Government (5517)
Grass and pollen (8)
Guidances (413)
Healthcare (21135)
HIV (84)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (104)
Immunology and inflammation (336)
Immuno-oncology (109)
Indications (195)
Infectious disease (3390)
Inflammatory bowel disease (238)
Inflation Reduction Act (16)
Influenza (142)
Intellectual property (300)
Interviews (820)
IPO (17963)
IRA (60)
Job creations (5205)
Job search strategy (2871)
JPM (71)
Kidney cancer (20)
Labor market (117)
Layoffs (681)
Leadership (52)
Legal (10158)
Liver cancer (108)
Longevity (35)
Lung cancer (810)
Lymphoma (436)
Machine learning (63)
Management (66)
Manufacturing (1139)
MASH (218)
Medical device (15065)
Medtech (15189)
Mergers & acquisitions (23200)
Metabolic disorders (1643)
mRNA (254)
Multiple sclerosis (198)
NASH (23)
Neurodegenerative disease (480)
Neuropsychiatric disorders (119)
Neuroscience (3597)
Neurotech (1)
NextGen: Class of 2026 (7691)
Non-profit (5134)
Now hiring (79)
Obesity (786)
Opinion (370)
Ovarian cancer (235)
Pain (263)
Pancreatic cancer (311)
Parkinson's disease (394)
Partnered (38)
Patents (602)
Patient recruitment (708)
Peanut (66)
People (67750)
Pharmaceutical (126)
Pharmacy benefit managers (36)
Phase 1 (24268)
Phase 2 (34113)
Phase 3 (25622)
Pipeline (9144)
Policy (382)
Postmarket research (3553)
Preclinical (10926)
Press Release (72)
Prostate cancer (323)
Psychedelics (65)
Radiopharmaceuticals (358)
Rare diseases (1195)
Real estate (7457)
Recruiting (81)
Regulatory (30017)
Reports (77)
Research institute (2757)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (92)
Schizophrenia (192)
Series A (314)
Series B (223)
Service/supplier (26)
Sickle cell disease (120)
Special edition (32)
Spinal muscular atrophy (188)
Sponsored (55)
Startups (4366)
State (2)
Stomach cancer (19)
Supply chain (138)
Tariffs (96)
The Weekly (142)
Vaccines (1259)
Venture capital (125)
Weight loss (527)
Women's health (133)
Worklife (24)
Date
Last 7 days (625)
Last 30 days (3246)
Last 365 days (31234)
2026 (14167)
2025 (31364)
2024 (37176)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1292)
Alabama (100)
Alaska (7)
Arizona (380)
Arkansas (15)
Asia (52097)
Australia (9167)
California (13619)
Canada (3791)
China (1474)
Colorado (573)
Connecticut (596)
Delaware (422)
Europe (120032)
Florida (2014)
Georgia (433)
Hawaii (4)
Idaho (70)
Illinois (1095)
India (99)
Indiana (636)
Iowa (25)
Japan (558)
Kansas (142)
Kentucky (49)
Louisiana (44)
Maine (85)
Maryland (1683)
Massachusetts (10017)
Michigan (395)
Minnesota (707)
Mississippi (7)
Missouri (154)
Montana (35)
Nebraska (30)
Nevada (147)
New Hampshire (83)
New Jersey (3644)
New Mexico (33)
New York (3595)
North Carolina (1867)
North Dakota (10)
Northern California (6810)
Ohio (413)
Oklahoma (22)
Oregon (52)
Pennsylvania (2723)
Puerto Rico (29)
Rhode Island (51)
South America (1668)
South Carolina (79)
South Dakota (2)
Southern California (5310)
Tennessee (203)
Texas (2161)
United States (48613)
Utah (389)
Vermont (1)
Virginia (331)
Washington D.C. (85)
Washington State (1121)
West Virginia (4)
Wisconsin (150)
Wyoming (2)
879,003 Results for "cha biotech cha bio and diostech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Envoy Medical Appoints Chas McKhann to Board of Directors
Proven Med Tech Leader with an Established Track Record of Commercial Success and Optimizing Shareholder Value Leading to over $3.4 Billion in Successful Exits
April 16, 2026
·
8 min read
Press Releases
BPGbio Appoints Former Oxford Pro-Vice Chancellor for Innovation Chas Bountra, Ph.D., as Executive Vice President and Chief Scientific Officer
April 21, 2026
·
3 min read
Insights
Inside Germany’s biotech capital infrastructure and innovation engine
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll be hearing from Regina Hodits, managing director at Angelini Ventures and Sofia Ioannidou, VC partner at Andera Life Sciences. They explore Germany’s biotech and life sciences ecosystem, including the science, infrastructure and policy changes needed to help European companies scale globally while staying rooted in Europe.
May 21, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Insights
France’s biotech ecosystem: science, capital and scale
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, managing partner at Kurma Partners. We dive into France’s biotech ecosystem and what still needs to happen for more early innovation to translate into investable, scalable biotech.
May 28, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Startup
Founders face pressure from all sides as biotech crawls toward recovery
In Salt Lake City, biotech founders new and seasoned reflect on ways to ride out the industry’s challenges, such as sending cold emails to investors and learning to address leadership weaknesses.
May 6, 2026
·
4 min read
·
Annalee Armstrong
Opinion
Biotech can’t continue to innovate under strain of Big Pharma market pressures
Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a discovery system built around scientific uncertainty. Structural changes are needed to sustain the sector’s strategic innovation.
May 19, 2026
·
5 min read
·
Jeremy Levin
Insights
Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
After years of contraction, investors see biotech reentering a growth cycle driven by scientific progress, asset quality and renewed conviction in oncology, obesity and neuroscience innovation.
January 29, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Press Releases
Exagen Inc. Appoints Chas McKhann to Board of Directors
July 18, 2025
·
4 min read
IPO
Biotech’s IPO tide is finally turning, thanks in part to the recent M&A surge
After years of suffering from a bear market and more than 14 months of geopolitical turmoil shaking the macroenvironment, biotech appears to be moving on.
May 12, 2026
·
5 min read
·
Gabrielle Masson
NEXTGEN
How To Shine As Biotech Comes Back From the Brink
Biotech has been pulling off some remarkable science of late, while M&A and IPOs return to bolster the sector. But that doesn’t mean the industry is back from the brink. BioSpace gathered three early-stage biotech CEOs and members of the NextGen Class of 2026 to talk about surviving and thriving in this rollercoaster market, all while bringing forward the next generation of medicines.
May 21, 2026
·
1 min read
·
Annalee Armstrong
1 of 87,901
Next